Arena Pharmaceuticals (ARNA)

8.00 +0.02  +0.25%  May 20, 10:44AM
Add to Watchlists Create an Alert

Arena Pharmaceuticals Accruals

Arena Pharmaceuticals Historical Accruals Data

Pro Data Export
Dates:  to
Viewing 1 of 2   First  Previous First    Next  Last   Last

There is no data for the selected date range.

Data for this Date Range  
Dec. 31, 2012 Go Pro
Sept. 30, 2012 Go Pro
June 30, 2012 Go Pro
March 31, 2012 Go Pro
Dec. 31, 2011 Go Pro
Sept. 30, 2011 Go Pro
June 30, 2011 Go Pro
March 31, 2011 Go Pro
Dec. 31, 2010 Go Pro
Sept. 30, 2010 Go Pro
June 30, 2010 Go Pro
March 31, 2010 Go Pro
Dec. 31, 2009 Go Pro
Sept. 30, 2009 Go Pro
June 30, 2009 Go Pro
March 31, 2009 Go Pro
Dec. 31, 2008 Go Pro
Sept. 30, 2008 Go Pro
June 30, 2008 Go Pro
March 31, 2008 Go Pro
Dec. 31, 2007 Go Pro
Sept. 30, 2007 Go Pro
June 30, 2007 Go Pro
March 31, 2007 Go Pro
Dec. 31, 2006 Go Pro
   
Sept. 30, 2006 Go Pro
June 30, 2006 Go Pro
March 31, 2006 Go Pro
Dec. 31, 2005 Go Pro
Sept. 30, 2005 Go Pro
June 30, 2005 Go Pro
March 31, 2005 Go Pro
Dec. 31, 2004 Go Pro
Sept. 30, 2004 Go Pro
June 30, 2004 Go Pro
March 31, 2004 Go Pro
Dec. 31, 2003 Go Pro
Sept. 30, 2003 Go Pro
June 30, 2003 Go Pro
March 31, 2003 Go Pro
Dec. 31, 2002 Go Pro
Sept. 30, 2002 Go Pro
June 30, 2002 Go Pro
March 31, 2002 Go Pro
Dec. 31, 2001 Go Pro
Sept. 30, 2001 Go Pro
June 30, 2001 Go Pro
March 31, 2001 Go Pro
Dec. 31, 2000 Go Pro
Sept. 30, 2000 Go Pro

About Accruals

Accruals are the non-cash net income earned by a business as a result of accrual based accounting. Mathematically, they are Net Income less Cash Flows from Operations.

Businesses with large positive accruals generally have large non-cash earnings like sales on account that have not yet been paid by customers. Those with negative accruals often are paid up-front for services and recognize the revenue over time as they perform the pre-paid service (newspapers are a good example of this type of business), or they may have large non-cash expenses such as depreciation.

Beware businesses that have large positive accruals over long periods of time. They are a signal of low quality earnings numbers (earnings without much actual cash behind them, in a simple sense). Accruals are also a key element of the Beneish M-Score which detects earnings manipulation, and companies with higher accruals relative to their assets are more likely to have been manipulating earnings.
Learn More

View Accruals for ARNA.
Start Your YCharts Pro Gold Membership.

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.

YCharts Pro is only $49/month, and comes with a 14-day free trial.

Get Started Now

Already a YCharts Pro Gold Member? Sign in here.

Get data for

ARNA Accruals Benchmarks

Companies
Vivus Go Pro
Orexigen Therapeutics Go Pro
Cytokinetics Go Pro

ARNA Accruals Rankings

Overall 57th percentile
3371 of 8002
Sector 22nd percentile
504 of 650 in Healthcare
Industry 17th percentile
196 of 237 in Biotechnology

ARNA Accruals Range, Past 5 Years

Minimum Go Pro Sep 2010
Maximum Go Pro Jun 2009
Average Go Pro